Search

1 Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney;... I Implementation Science 2023, i B 18(2): b SP a sp Mitchell Sarkies and Hossai Gul contributed equally to this paper SP b sp Andrew Baillie, Lauren Christie, Caleb Ferguson, Julie Gawthorne, Helen Goldsmith, Nicolette Hodyl, Natasha Howard, Karen Hutchinson, Marlena Klaic, Joanna Moullin, Nicole Nathan, Sanne Peters, Nicole Rankin, Ben Smith, Serene Yoong. Only one study reported facilitators to the IMPLEMENTATION of CDS systems, none reported on barriers to the implementation of CDS systems and none reported any information on successful strategies to MAINTAIN implementation of CDS systems. B Methods b A sequence of three studies were conducted via a mixed method methodology and structured by the process model Implementation Mapping (IM) to guide the development of implementation strategies. B Conclusions b Process mapping successfully identifies site-specific variation in complex clinical processes and facilitates a shared understanding of the current systems and factors that affect implementation. [Extracted from the article]

The text provides a summary of various research studies and initiatives related to implementation science in healthcare settings. The studies cover a wide range of topics, including the implementation of interventions for different health issues, the use of implementation strategies, and the challenges and opportunities in implementing evidence-based practices. The findings highlight the importance of tailoring strategies to specific contexts, engaging stakeholders, and addressing barriers to successful implementation. The studies provide valuable insights for researchers, practitioners, and policymakers interested in improving the implementation of interventions in diverse healthcare settings. [Extracted from the article]

Background: Methods of sustaining the deimplementation of overused medical practices (i.e., practices not supported by evidence) are understudied. In pediatric hospital medicine, continuous pulse oximetry monitoring of children with the common viral respiratory illness bronchiolitis is recommended only under specific circumstances. Three national guidelines discourage its use for children who are not receiving supplemental oxygen, but guideline-discordant practice (i.e., overuse) remains prevalent. A 6-hospital pilot of educational outreach with audit and feedback resulted in immediate reductions in overuse; however, the best strategies to optimize sustainment of deimplementation success are unknown.Methods: The Eliminating Monitor Overuse (EMO) trial will compare two deimplementation strategies in a hybrid type III effectiveness-deimplementation trial. This longitudinal cluster-randomized design will be conducted in Pediatric Research in Inpatient Settings (PRIS) Network hospitals and will include baseline measurement, active deimplementation, and sustainment phases. After a baseline measurement period, 16-19 hospitals will be randomized to a deimplementation strategy that targets unlearning (educational outreach with audit and feedback), and the other 16-19 will be randomized to a strategy that targets unlearning and substitution (adding an EHR-integrated clinical pathway decision support tool). The primary outcome is the sustainment of deimplementation in bronchiolitis patients who are not receiving any supplemental oxygen, analyzed as a longitudinal difference-in-differences comparison of overuse rates across study arms. Secondary outcomes include equity of deimplementation and the fidelity to, and cost of, each deimplementation strategy. To understand how the deimplementation strategies work, we will test hypothesized mechanisms of routinization (clinicians developing new routines supporting practice change) and institutionalization (embedding of practice change into existing organizational systems).Discussion: The EMO trial will advance the science of deimplementation by providing new insights into the processes, mechanisms, costs, and likelihood of sustained practice change using rigorously designed deimplementation strategies. The trial will also advance care for a high-incidence, costly pediatric lung disease.Trial Registration: ClinicalTrials.gov, NCT05132322 . Registered on November 10, 2021. [ABSTRACT FROM AUTHOR]